Senseonics’ plans to roll out its new, long-term diabetes sensor implant will be pushed to the middle of next year as…
Browsing: BioTech
After suffering a complete response letter a little over a month ago, Alkermes quickly sorted out the manufacturing shortfalls that…
Japanese pharma Astellas and its new biotech buyout Audentes got a Christmas gift from the FDA when the agency lifted…
The National Institutes of Health (NIH) awarded over $107 million for what it describes as “radical approaches” to testing for…
A phase 3 clinical trial of Amgen and AstraZeneca’s asthma candidate tezepelumab has missed its primary endpoint. The failure comes…
In a typical year, I’d compile our annual roundup of top stories while searching for photos of gold confetti and…
Vertex has secured exclusive options to license Skyhawk Therapeutics’ candidates that modulate RNA splicing. The deal will see Vertex pay…
In the final act of the 2011 film “Contagion,” people wore bar-coded wristbands to prove they had been inoculated against…
Beckman Coulter plans to launch a $4 coronavirus antigen test designed for mass screening, with the goal of shipping up…
San Diego biotech Janux Therapeutics has penned a major biobucks R&D pact focused on next generation T-cell engager immunotherapies in…